Clinical Observation of Shenmai Injection in Treatment of Primary Sjogren Syndrome / 中国药房
China Pharmacy
;
(12)2001.
Artículo
en Chino
| WPRIM
| ID: wpr-533603
ABSTRACT
OBJECTIVE:
To observe the clinical effect of Shenmai injection for primary sjogren syndrome.METHODS:
61 patients were randomized to receive anethole trithione (control group,n=29) or anethole trithione and Shenmai injection (treatment group,n=32) respectively with 15 days as a course of treatment.RESULTS:
The total effective rate was 68.96% for control group and 90.63% for treatment group.There were 3 cases of abdominal discomfort ordiarrhea in control group,and no serious ADR was detected in treatment group.Significant difference was noted between two groups (P
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Tipo de estudio:
Ensayo Clínico Controlado
Idioma:
Chino
Revista:
China Pharmacy
Año:
2001
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS